ZA949900B - Direct compression formulation containing paraxetine - Google Patents

Direct compression formulation containing paraxetine

Info

Publication number
ZA949900B
ZA949900B ZA949900A ZA949900A ZA949900B ZA 949900 B ZA949900 B ZA 949900B ZA 949900 A ZA949900 A ZA 949900A ZA 949900 A ZA949900 A ZA 949900A ZA 949900 B ZA949900 B ZA 949900B
Authority
ZA
South Africa
Prior art keywords
paraxetine
formulation containing
direct compression
compression formulation
direct
Prior art date
Application number
ZA949900A
Other languages
English (en)
Inventor
Ram Dutta Pathak
David George Doughty
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA949900(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA949900B publication Critical patent/ZA949900B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA949900A 1993-12-15 1994-12-13 Direct compression formulation containing paraxetine ZA949900B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation

Publications (1)

Publication Number Publication Date
ZA949900B true ZA949900B (en) 1995-10-10

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949900A ZA949900B (en) 1993-12-15 1994-12-13 Direct compression formulation containing paraxetine

Country Status (36)

Country Link
US (1) US6113944A (sk)
EP (1) EP0734260B2 (sk)
JP (1) JP3037757B2 (sk)
KR (1) KR100367796B1 (sk)
CN (1) CN1071116C (sk)
AP (1) AP540A (sk)
AT (1) ATE180973T1 (sk)
AU (1) AU697982B2 (sk)
BG (1) BG62755B1 (sk)
BR (1) BR9408219A (sk)
CA (4) CA2214575C (sk)
CZ (1) CZ287891B6 (sk)
DE (1) DE69419033T2 (sk)
DK (1) DK0734260T4 (sk)
DZ (1) DZ1835A1 (sk)
ES (1) ES2132610T5 (sk)
FI (1) FI962445A (sk)
GB (1) GB9325644D0 (sk)
GR (1) GR3031047T3 (sk)
HK (1) HK1012285A1 (sk)
HU (1) HUT75880A (sk)
IL (1) IL111978A (sk)
MA (1) MA23395A1 (sk)
MY (1) MY112123A (sk)
NO (1) NO307366B1 (sk)
NZ (1) NZ277790A (sk)
OA (1) OA10297A (sk)
PL (1) PL314980A1 (sk)
RO (1) RO115413B1 (sk)
RU (1) RU2146141C1 (sk)
SA (1) SA94150373B1 (sk)
SI (1) SI0734260T2 (sk)
SK (1) SK282620B6 (sk)
UA (1) UA42745C2 (sk)
WO (1) WO1995016448A1 (sk)
ZA (1) ZA949900B (sk)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
PT994872E (pt) 1997-06-10 2001-09-28 Synthon Bv Composto de 4-fenilpiperidina
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
WO2002017921A2 (en) * 2000-08-28 2002-03-07 Synthon B.V. Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
CN1660074A (zh) 2001-07-31 2005-08-31 H·隆德贝克有限公司 含有依他普仑的晶体组合物
NZ532432A (en) * 2001-10-22 2005-02-25 Synthon Bv N-formyl paroxetine compounds and their use in a synthetic route for obtaining paroxetine
CA2471715A1 (en) * 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
AU2005265174A1 (en) * 2004-06-23 2006-01-26 Merck & Co., Inc. Estrogen receptor modulators
WO2006018318A1 (en) * 2004-08-18 2006-02-23 Synthon B.V. Liquid paroxetine compositions
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
US20070112031A1 (en) * 2005-11-14 2007-05-17 Gant Thomas G Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (sk) * 1974-03-04 1975-09-11
ZA813205B (en) † 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
JPH06502854A (ja) * 1990-11-24 1994-03-31 ビーチャム・グループ・パブリック・リミテッド・カンパニー 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
WO1995016448A1 (en) 1995-06-22
IL111978A0 (en) 1995-03-15
HUT75880A (en) 1997-05-28
CN1071116C (zh) 2001-09-19
SA94150373B1 (ar) 2006-05-27
CA2214575A1 (en) 1995-06-22
NO307366B1 (no) 2000-03-27
GB9325644D0 (en) 1994-02-16
SK282620B6 (sk) 2002-10-08
BG62755B1 (bg) 2000-07-31
AP9400704A0 (en) 1995-01-31
PL314980A1 (en) 1996-09-30
CA2178637C (en) 1997-12-23
KR100367796B1 (ko) 2003-07-22
CZ176396A3 (en) 1996-09-11
EP0734260B2 (en) 2008-07-09
AP540A (en) 1996-09-20
CN1137236A (zh) 1996-12-04
DK0734260T3 (da) 1999-11-15
AU1314595A (en) 1995-07-03
NZ277790A (en) 1998-02-26
NO962547D0 (no) 1996-06-14
SI0734260T2 (sl) 2008-12-31
FI962445A0 (fi) 1996-06-12
HK1012285A1 (en) 1999-07-30
MA23395A1 (fr) 1995-07-01
JPH09506602A (ja) 1997-06-30
DK0734260T4 (da) 2008-09-29
AU697982B2 (en) 1998-10-22
GR3031047T3 (en) 1999-12-31
DZ1835A1 (fr) 2002-02-17
ATE180973T1 (de) 1999-06-15
EP0734260B1 (en) 1999-06-09
RU2146141C1 (ru) 2000-03-10
CA2178637A1 (en) 1995-06-22
DE69419033T2 (de) 1999-11-25
CA2214575C (en) 1999-12-07
SI0734260T1 (en) 1999-08-31
NO962547L (no) 1996-06-14
BG100648A (bg) 1997-02-28
CZ287891B6 (cs) 2001-03-14
SA94150373A (ar) 2005-12-03
FI962445A (fi) 1996-06-12
US6113944A (en) 2000-09-05
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
ES2132610T3 (es) 1999-08-16
IL111978A (en) 2000-07-16
BR9408219A (pt) 1997-08-26
DE69419033D1 (de) 1999-07-15
JP3037757B2 (ja) 2000-05-08
ES2132610T5 (es) 2008-12-16
MY112123A (en) 2001-04-30
RO115413B1 (ro) 2000-02-28
CA2274389C (en) 2004-09-14
CA2274387A1 (en) 1995-06-22
CA2274389A1 (en) 1995-06-22
UA42745C2 (uk) 2001-11-15
EP0734260A1 (en) 1996-10-02
HU9601665D0 (en) 1996-08-28

Similar Documents

Publication Publication Date Title
ZA949900B (en) Direct compression formulation containing paraxetine
GB9308103D0 (en) Cosmetic composition
GB9402029D0 (en) Novel formulation
GB9315755D0 (en) Stabilized formulation
GB9221883D0 (en) Novel formulation
GB9316326D0 (en) Novel formulation
GB9312355D0 (en) Novel formulation
GB9312354D0 (en) Novel formulation
GB9312938D0 (en) Formulation
GB9302189D0 (en) Formulation
GB9312960D0 (en) Formulation
GB9325869D0 (en) Formulation
GB9212757D0 (en) Novel formulation
GB9212711D0 (en) Novel formulation
GB9216361D0 (en) Novel formulation
ZA928061B (en) Lipomimetic formulation
GB9201915D0 (en) Formulation
GB9225583D0 (en) Formulation
GB9202110D0 (en) Formulation
GB9205183D0 (en) Formulation
GB9217322D0 (en) Formulation
GB9311349D0 (en) Compression fitting
IL105978A0 (en) Shampoo formulation
GB9306144D0 (en) Formulations
GB9308622D0 (en) Formulations